skip to main content

Equity and Inclusion at the U-M Rogel Cancer Center

The Rogel Cancer Center joins with our communities of color, and all Americans, to express our outrage and heartbreak over the continued racism and injustice tearing at the fabric of civil society.

Providing Safe Cancer Care in the Time of COVID

Leaders and care teams across our center are working tirelessly to provide safe cancer care during the COVID pandemic.

ResearcHERS campaign brings attention to women cancer researchers

A group of a dozen U-M women researchers are pushing forward participating in ResearcHERs, an American Cancer Society campaign that gives women the opportunity to raise funds to fuel the work of female scientists.

Rogel Cancer Center names 2 Forbes Scholars to fuel translational research

The Forbes Institute for Cancer Research at the University of Michigan Rogel Cancer Center will fund two researchers pursuing promising new treatment approaches for brain and ovarian cancers. Maria G. Castro, Ph.D., and Deepak Nagrath, Ph.D., will receive one-year grants of $250,000 each as 2020 Forbes Scholars.

Previous Forbes Scholars

image of a lab technician in profile

        2019        |        2018        |        2017

U-M Study Offers Clues About How Gut Microbiomes Impact Colorectal Cancer

Some types of gut bacteria are better than others at stimulating certain immune cells, specifically CD8+ T cells, in the body, they found.

Researchers may have Found a Way to Diagnose Rare Kidney Cancer Earlier

Using next-generation RNA sequencing techniques, a team of scientists from the University of Michigan Rogel Cancer Center has uncovered the gene signature of chromophobe renal cell carcinoma (ChRCC) and have extensively tested the expression of three new biomarkers.

Pages